S0220: Chemoradiotherapy Followed By Surgery and Docetaxel in Treating Patients With Pancoast Tumors
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cisplatin, etoposide, and docetaxel, use
different ways to stop tumor cells from dividing so they stop growing or die. Radiation
therapy uses high-energy x-rays to damage tumor cells. Combining cisplatin and etoposide with
radiation therapy may shrink the tumor so it can be removed by surgery. Giving docetaxel
after surgery may kill any remaining tumor cells.
PURPOSE: This phase II trial is studying how well giving chemoradiotherapy together with
cisplatin and etoposide followed by surgery and docetaxel works in treating patients with
newly diagnosed Pancoast tumors, a type of non-small cell lung cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Southwest Oncology Group
Collaborators:
American College of Surgeons Cancer and Leukemia Group B Eastern Cooperative Oncology Group National Cancer Institute (NCI) NCIC Clinical Trials Group North Central Cancer Treatment Group